John W Lewis

Title: The Innovations of John W. Lewis

Introduction

John W. Lewis is a notable inventor based in North Ferriby, GB, recognized for his contributions to pharmaceutical compositions aimed at treating opiate dependence. With a total of six patents to his name, Lewis has made significant strides in the field of medicine, particularly in developing effective treatments for addiction.

Latest Patents

One of his latest patents focuses on treating opiate dependence. This pharmaceutical composition is designed in a sublingual unit dosage form for the maintenance treatment of opiate addicts. It comprises from 2 to 8 mg of buprenorphine and an amount of naltrexone sufficient to substantially attenuate the euphorigenic effect of buprenorphine when injected. This innovative approach provides a greater opiate blocking effect than that of naltrexone alone. Another significant patent involves a derivative of codeine, which is useful as an agonist. This patent describes a compound that exhibits analgesic activity and includes a process for its preparation along with pharmaceutical compositions comprising the compound or a pharmaceutically acceptable salt thereof.

Career Highlights

John W. Lewis is associated with Reckitt & Colman Products Limited, where he has contributed to the development of various pharmaceutical products. His work has been instrumental in advancing treatment options for individuals struggling with opiate addiction.

Collaborations

Lewis has collaborated with notable coworkers, including John G. Lloyd-Jones and Ryszard J. Kobylecki, enhancing the innovative efforts within his field.

Conclusion

John W. Lewis's contributions to pharmaceutical innovations, particularly in the treatment of opiate dependence, highlight his significant role in advancing medical science. His patents reflect a commitment to improving the lives of those affected by addiction.